posted on 2017-08-22, 20:14authored byPatrick J. Morris, Ruin Moaddel, Panos Zanos, Curtis E. Moore, Todd Gould, Carlos A. Zarate, Craig J. Thomas
Ketamine
is rapidly metabolized in the human body to a variety
of metabolites, including the hydroxynorketamines. At least
two hydroxynorketamines have significant antidepressant action
in rodent models, with limited action against the N-methyl-d-aspartate (NMDA) receptor. The synthesis of 12
hydroxynorketamines and their binding affinity to the NMDA receptor
is presented here.